Ibandronate treatment reverses glucocorticoid-induced loss of bone mineral density and strength in minipigs.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Bone

• Publication date

  2007-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.BONE.2006.10.019PMID 17174621
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Steroid-induced osteoporosis

  2010cited by this paper
• Vitamin K deficiency affects calcium retention, bone mineralization and APb in growing and ovariectomized rats

  2006cited by this paper
• Modulation of bone markers by dietary calcium in ovariectomized minipigs

  2006cited by this paper
• High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study.

  2006cited by this paper
• Undecalcified preparation of bone tissue: Report of technical experience and development of new methods

  2005cited by this paper
• Histomorphometric analysis of glucocorticoid-induced osteoporosis.

  2005cited by this paper
• Inhibition of cortical and cancellous bone formation in glucocorticoid-treated OVX sheep.

  2005cited by this paper
• A Histomorphometric Study of Cortical Bone of the Iliac Crest in Patients Treated with Glucocorticoids

  2005cited by this paper
• Accurate assessment of precision errors: How to measure the reproducibility of bone densitometry techniques

  2005cited by this paper
• Glucocorticoid-Induced Osteoporosis

  2004cited by this paper
• Perspectives on glucocorticoid-induced osteoporosis.

  2004cited by this paper
• US and UK guidelines for glucocorticoid-induced osteoporosis: Similarities and differences

  2004cited by this paper
• Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength.

  2004cited by this paper
• Glucocorticoid-treated sheep as a model for osteopenic trabecular bone in biomaterials research.

  2003cited by this paper
• Osteocyte viability with glucocorticoid treatment: relation to histomorphometry

  2003cited by this paper
• Glucocorticoid Treatment of Ovariectomized Sheep Affects Mineral Density, Structure, and Mechanical Properties of Cancellous Bone

  2003cited by this paper
• Intermittent intravenous ibandronate injections reduce vertebral fracture risk in corticosteroid-induced osteoporosis: results from a long-term comparative study

  2003cited by this paper
• DVO-Leitlinie Glukokortikoidinduzierte Osteoporose

  2003cited by this paper
• Intermittent intravenous administration of the bisphosphonate ibandronate prevents bone loss and maintains bone strength and quality in ovariectomized cynomolgus monkeys.

  2003cited by this paper
• Reductions in bone turnover, mineral, and structure associated with mechanical properties of lumbar vertebra and femur in glucocorticoid-treated growing minipigs.

  2003cited by this paper
• Bone Changes due to Glucocorticoid Application in an Ovariectomized Animal Model for Fracture Treatment in Osteoporosis

  2002influential reference
• The Comparative Efficacy of Drug Therapies Used for the Management of Corticosteroid‐Induced Osteoporosis: A Meta‐Regression

  2002cited by this paper
• Effects of methylprednisolone on bone formation and resorption in rats.

  2002cited by this paper
• Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids.

  2002cited by this paper
• Effects of treatment with ibandronate on bone mass, architecture, biomechanical properties, and bone concentration of ibandronate in ovariectomized aged rats.

  2002cited by this paper
• Risedronate Preserves Trabecular Architecture and Increases Bone Strength in Vertebra of Ovariectomized Minipigs as Measured by Three‐Dimensional Microcomputed Tomography

  2002cited by this paper
• Effect of Ovariectomy, Malnutrition and Glucocorticoid Application on Bone Properties in Sheep: A Pilot Study

  2002cited by this paper
• Alendronate increases bone mass and reduces bone markers in postmenopausal African-American women.

  2002cited by this paper
• Total administered dose of ibandronate determines its effects on bone mass and architecture in ovariectomized aged rats.

  2002cited by this paper
• The Epidemiology of Corticosteroid-Induced Osteoporosis: a Meta-analysis

  2002cited by this paper
• Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial.

  2001cited by this paper
• Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 Update: American College of Rheumatology Ad Hoc Committee on glucocorticoid-induced osteoporosis

  2001cited by this paper
• Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.

  2001cited by this paper
• Comparison of Trabecular Bone Microarchitecture and Remodeling in Glucocorticoid‐Induced and Postmenopausal Osteoporosis

  2001cited by this paper
• Inhomogeneity of human vertebral cancellous bone: systematic density and structure patterns inside the vertebral body.

  2001cited by this paper
• Effect of high doses of oral risedronate (20 mg/day) on serum parathyroid hormone levels and urinary collagen cross-link excretion in postmenopausal women with spinal osteoporosis.

  2001cited by this paper
• Effects of Risedronate Treatment on Bone Density and Vertebral Fracture in Patients on Corticosteroid Therapy

  2000cited by this paper
• Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study.

  2000cited by this paper
• Association between histomorphometry and biochemical markers of bone turnover in a longitudinal rat model of parathyroid hormone-related peptide (PTHrP)-mediated tumor osteolysis.

  2000cited by this paper
• A new method of comprehensive static histomorphometry applied on human lumbar vertebral cancellous bone.

  2000cited by this paper
• Trabecular architecture in women and men of similar bone mass with and without vertebral fracture: II. Three-dimensional histology.

  2000cited by this paper
• Trabecular architecture in women and men of similar bone mass with and without vertebral fracture: I. Two-dimensional histology.

  2000cited by this paper
• Prevention of Bone Loss with Risedronate in Glucocorticoid-Treated Rheumatoid Arthritis Patients

  2000cited by this paper
• Efficacy and Safety of Daily Risedronate in the Treatment of Corticosteroid‐Induced Osteoporosis in Men and Women: A Randomized Trial

  2000cited by this paper
• Intermittent and Continuous Administration of the Bisphosphonate Ibandronate in Ovariohysterectomized Beagle Dogs: Effects on Bone Morphometry and Mineral Properties

  1999cited by this paper
• Tamoxifen attenuates the effects of exogenous glucocorticoid on bone formation and growth in piglets.

  1998cited by this paper
• Effects of pamidronate on the development of changes in bone mechanical properties and bone structure caused by the administration of prednisolone in rats.

  1998cited by this paper
• Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis

  1998cited by this paper
• Relationships between static histomorphometry and bone strength measurements in human iliac crest bone biopsies.

  1998cited by this paper
• Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group.

  1998cited by this paper
• Prevention of Corticosteroid-Induced Bone Loss with Alendronate

  1998cited by this paper
• Zoledronate Prevents the Development of Absolute Osteopenia Following Ovariectomy in Adult Rhesus Monkeys

  1998cited by this paper
• Prednisolone alone, or in combination with estrogen or dietary calcium deficiency or immobilization, inhibits bone formation but does not induce bone loss in mature rats.

  1997cited by this paper
• Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis.

  1997cited by this paper
• Short-term effects of corticosteroids on trabecular bone remodeling in old ewes.

  1997cited by this paper
• Effects of continuous glucocorticoid infusion on bone metabolism in the rat

  1996cited by this paper
• Effect of ovariectomy on bone histology and plasma parameters of bone metabolism in nulliparous and multiparous sows

  1996cited by this paper
• Effects of selected thermal variables on the mechanical properties of trabecular bone.

  1995cited by this paper
• Comparison between bone density and bone strength in glucocorticoid-treated aged ewes.

  1995cited by this paper
• Rapid method for the isolation of the mature collagen cross-links, hydroxylysylpyridinoline and lysylpyridinoline.

  1994cited by this paper
• Evaluation of the skeletal effects of combined mild dietary calcium restriction and ovariectomy in sinclair S‐1 minipigs: A pilot study

  1993cited by this paper
• The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates.

  1993cited by this paper
• Glucocorticoid-induced inhibition of osteoblastic bone formation in ewes: A biochemical and histomorphometric study

  1993cited by this paper
• A new bisphosphonate, BM 21.0955, prevents bone loss associated with cessation of ovarian function in experimental dogs

  1993cited by this paper
• Salmon calcitonin reduces vertebral bone loss in glucocorticoid-treated beagles.

  1993cited by this paper
• The effect of specimen geometry on the mechanical behaviour of trabecular bone specimens.

  1992cited by this paper
• Effects of corticosteroids on mechanical strength of intervertebral joints and vertebrae in dogs.

  1990cited by this paper
• Bone loss in response to long-term glucocorticoid therapy.

  1990cited by this paper
• Effects of corticosteroids on mechanical strength of intervertebral joints and vertebrae in dogs.

  1990cited by this paper
• PATHOGENESIS AND TREATMENT OF STEROID OSTEOPOROSIS

  1989cited by this paper
• Reference values for trabecular and cortical vertebral bone density in single and dual-energy quantitative computed tomography.

  1989cited by this paper
• [Inhibition of prednisolone osteopathy by diphosphonate (EHDP) in an animal experiment].

  1989cited by this paper
• Vertebral bone mineral analysis: an integrated approach with CT.

  1987cited by this paper
• Procedures for Detecting Outlying Observations in Samples

  1969cited by this paper

• Effects of beak-treatment styles on beak morphology and production performance of layer chicks aged 0–8 weeks

  2025influential citation
• Bone samples’ behavior in sunlight, IR light, and temperature increase with FEM simulation

  2023cites this paper
• Are pigs a suitable model species for osteoporosis research?

  2020cites this paper
• New Targets and Emergent Therapies for Osteoporosis.

  2019cites this paper
• Porcine induced pluripotent stem cell-derived osteoblast-like cells prevent glucocorticoid-induced bone loss in Lanyu pigs

  2018cites this paper
• Biological fractionation of stable Ca isotopes in Göttingen minipigs as a physiological model for Ca homeostasis in humans

  2016cites this paper
• Zoledronate induces bisphosphonate-related osteonecrosis of the jaw in osteopenic sheep

  2015cites this paper
• Animal Models of Bone Disease-B

  2013cites this paper
• Housing in the Animal Enclosure Module Spaceflight Hardware Increases Trabecular Bone Mass in Ground-Control Mice

  2013cites this paper
• Modulation of Vitamin D Status and Dietary Calcium Affects Bone Mineral Density and Mineral Metabolism in Göttingen Minipigs

  2013influential citation
• Biomechanical effects of simulated resorption cavities in cancellous bone across a wide range of bone volume fractions

  2012cites this paper
• Ibandronate for prevention and treatment of glucocorticoid-induced osteoporosis in rabbits

  2012cites this paper
• Großtiermodelle der Osteoporose

  2011cites this paper
• Advanced imaging assessment of bone fragility in glucocorticoid-induced osteoporosis.

  2011cites this paper
• How to Select Your Animal Model for Osteoporosis Research

  2011cites this paper
• Other Large Animal Models

  2011cites this paper
• Glucocorticoid-Induced Osteoporosis: A Review

  2010cites this paper
• Intravenous ibandronate rapidly reduces pain, neurochemical indices of central sensitization, tumor burden, and skeletal destruction in a mouse model of bone cancer.

  2008cites this paper
• Recent Advances in the Management of Steroid Induced Osteoporosis

  2008cites this paper
• Review of Nonprimate, Large Animal Models for Osteoporosis Research

  2008influential citation
• Glucocorticoid-induced osteoporosis: clinical and therapeutic aspects.

  2007cites this paper
• Minipigs and potbellied pigs as pets in the veterinary practice--a retrospective study.

  2007cites this paper
• Glucocorticosteroid-induced osteoporosis in adult primiparous Göttingen miniature pigs: effects on bone mineral and mineral metabolism.

  2007cites this paper